19
4.5. Other Populations at Risk
COR LOE
Recommendation
Ethnicity
IIa B-NR 1. For clinical decision-making in adults of different race/
ethnicities, it is reasonable for clinicians to review race/ethnic
features that can influence ASCVD risk so as to adjust choice
of statin or intensity of treatment.
Table 8. Racial/Ethnic Issues in Evaluation, Risk Decisions,
and Treatment of ASCVD Risk
Racial/Ethnic Groupings
Asian
Americans
a
Hispanic/Latino
Americans
b
Blacks Comments
Evaluation
ASCVD
issues
informed by
race/ethnicity
ASCVD risk
in people of
South Asian
and East Asian
origin varies
by country
of origin;
individuals
from South
Asia (see
below) have
increased
ASCVD risk.
Race/ethnicity
and country
of origin,
together with
socioeconomic
status and
acculturation
level, may explain
risk factor burden
more precisely
(e.g., ASCVD risk
is higher among
individuals from
Puerto Rico
than those from
Mexico).
ASCVD risk
assessment in
black women
shows
increased
ASCVD risk
compared
with their
otherwise
similar white
counterparts.
ere is
heterogeneity
in risk
according
to racial/
ethnic group
and within
racial/ethnic
groups. Native
American/
Alaskan
populations
have high rates
of risk factors
for ASCVD
compared with
non-Hispanic
whites.
